Prostate Cancer Diagnostics Market
Prostate Cancer Diagnostics Market Analysis By Test Type (PSA, PCA3, CTC & Immunohistochemistry Prostate Cancer Diagnostic Test), By End User (Prostate Cancer Diagnostics in Hospitals, Prostate Cancer Diagnostics in Cancer Research Institutes) - Global Market insights 2021 to 2031
Analysis of Prostate Cancer Diagnostics market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Table of Content
Chapter 1. Global Prostate Cancer Diagnostics Market - Executive Summary. 11 Chapter 2. Global Prostate Cancer Diagnostics Market Overview. 13 2.1. Introduction. 13 2.1.1. Global Prostate Cancer Diagnostics Market Taxonomy. 13 2.1.2. Global Prostate Cancer Diagnostics Market Definition. 13 2.2. Global Prostate Cancer Diagnostics Market Size (US$ Mn) and Forecast, 2016-2031. 14 2.2.1. Global Prostate Cancer Diagnostics Market Y-o-Y Growth. 14 2.3. Global Prostate Cancer Diagnostics Market Dynamics. 14 2.3.1. Drivers. 14 2.3.2. Restraints. 14 2.3.3. Trends. 15 2.4. Supply Chain. 15 2.5. Epidemiology. 15 2.6. Key Participants Market Presence (Intensity Map) By Region. 15 Chapter 3. Global Prostate Cancer Diagnostics Market Analysis and Forecast By Test Type. 16 3.1. Global Prostate Cancer Diagnostics Market Size and Forecast By Test Type, 2016-2031. 16 3.1.1. PSA Tests Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 16 3.1.1.1. Revenue (US$ Mn) Comparison, By Region. 16 3.1.1.2. Market Share Comparison, By Region. 18 3.1.1.3. Y-o-Y growth Comparison, By Region. 18 3.1.2. CTC Tests Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 19 3.1.2.1. Revenue (US$ Mn) Comparison, By Region. 19 3.1.2.2. Market Share Comparison, By Region. 21 3.1.2.3. Y-o-Y growth Comparison, By Region. 21 3.1.3. Immunohistochemistry Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 22 3.1.3.1. Revenue (US$ Mn) Comparison, By Region. 22 3.1.3.2. Market Share Comparison, By Region. 24 3.1.3.3. Y-o-Y growth Comparison, By Region. 24 3.1.4. PCA3 test Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 25 3.1.4.1. Revenue (US$ Mn) Comparison, By Region. 25 3.1.4.2. Market Share Comparison, By Region. 27 3.1.4.3. Y-o-Y growth Comparison, By Region. 27 3.1.5. Others Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 28 3.1.5.1. Revenue (US$ Mn) Comparison, By Region. 28 3.1.5.2. Market Share Comparison, By Region. 30 3.1.5.3. Y-o-Y growth Comparison, By Region. 30 Chapter 4. Global Prostate Cancer Diagnostics Market Analysis and Forecast By End User. 32 4.1. Global Prostate Cancer Diagnostics Market Size and Forecast By End User, 2016-2031. 32 4.1.1. Hospital Associated Labs Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 32 4.1.1.1. Revenue (US$ Mn) Comparison, By Region. 32 4.1.1.2. Market Share Comparison, By Region. 34 4.1.1.3. Y-o-Y growth Comparison, By Region. 34 4.1.2. Independent Diagnostic Laboratories Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 35 4.1.2.1. Revenue (US$ Mn) Comparison, By Region. 35 4.1.2.2. Market Share Comparison, By Region. 37 4.1.2.3. Y-o-Y growth Comparison, By Region. 37 4.1.3. Cancer Research Institutes Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 38 4.1.3.1. Revenue (US$ Mn) Comparison, By Region. 38 4.1.3.2. Market Share Comparison, By Region. 40 4.1.3.3. Y-o-Y growth Comparison, By Region. 40 4.1.4. Others Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 41 4.1.4.1. Revenue (US$ Mn) Comparison, By Region. 41 4.1.4.2. Market Share Comparison, By Region. 43 4.1.4.3. Y-o-Y growth Comparison, By Region. 43 Chapter 5. Global Prostate Cancer Diagnostics Market Analysis and Forecast By Region. 45 5.1. Global Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 45 5.1.1. North America Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 45 5.1.1.1. Revenue (US$ Mn) Comparison, By Test Type. 45 5.1.1.2. Revenue (US$ Mn) Comparison, By End User. 46 5.1.2. Latin America Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 48 5.1.2.1. Revenue (US$ Mn) Comparison, By Test Type. 48 5.1.2.2. Revenue (US$ Mn) Comparison, By End User. 50 5.1.3. Europe Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 52 5.1.3.1. Revenue (US$ Mn) Comparison, By Test Type. 52 5.1.3.2. Revenue (US$ Mn) Comparison, By End User. 53 5.1.4. Japan Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 55 5.1.4.1. Revenue (US$ Mn) Comparison, By Test Type. 55 5.1.4.2. Revenue (US$ Mn) Comparison, By End User. 57 5.1.5. APEJ Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 58 5.1.5.1. Revenue (US$ Mn) Comparison, By Test Type. 58 5.1.5.2. Revenue (US$ Mn) Comparison, By End User. 60 5.1.6. MEA Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 62 5.1.6.1. Revenue (US$ Mn) Comparison, By Test Type. 62 5.1.6.2. Revenue (US$ Mn) Comparison, By End User. 63 Chapter 6. North America Prostate Cancer Diagnostics Market Analysis and Forecast, By Country, 2016-2031. 66 6.1. US Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 66 6.1.1. Revenue (US$ Mn) Comparison, By Test Type. 66 6.1.2. Revenue (US$ Mn) Comparison, By End User. 67 6.2. Canada Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 68 6.2.1. Revenue (US$ Mn) Comparison, By Test Type. 68 6.2.2. Revenue (US$ Mn) Comparison, By End User. 69 Chapter 7. Latin America Prostate Cancer Diagnostics Market Analysis and Forecast, By Country, 2016-2031. 70 7.1. Brazil Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 70 7.1.1. Revenue (US$ Mn) Comparison, By Test Type. 70 7.1.2. Revenue (US$ Mn) Comparison, By End User. 71 7.2. Mexico Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 72 7.2.1. Revenue (US$ Mn) Comparison, By Test Type. 72 7.2.2. Revenue (US$ Mn) Comparison, By End User. 73 7.3. Argentina Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 74 7.3.1. Revenue (US$ Mn) Comparison, By Test Type. 74 7.3.2. Revenue (US$ Mn) Comparison, By End User. 75 Chapter 8. Europe Prostate Cancer Diagnostics Market Analysis and Forecast, By Country, 2016-2031. 76 8.1. Germany Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 76 8.1.1. Revenue (US$ Mn) Comparison, By Test Type. 76 8.1.2. Revenue (US$ Mn) Comparison, By End User. 77 8.2. UK Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 78 8.2.1. Revenue (US$ Mn) Comparison, By Test Type. 78 8.2.2. Revenue (US$ Mn) Comparison, By End User. 79 8.3. France Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 80 8.3.1. Revenue (US$ Mn) Comparison, By Test Type. 80 8.3.2. Revenue (US$ Mn) Comparison, By End User. 81 8.4. Spain Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 82 8.4.1. Revenue (US$ Mn) Comparison, By Test Type. 82 8.4.2. Revenue (US$ Mn) Comparison, By End User. 83 8.5. Italy Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 84 8.5.1. Revenue (US$ Mn) Comparison, By Test Type. 84 8.5.2. Revenue (US$ Mn) Comparison, By End User. 85 8.6. Nordic Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 86 8.6.1. Revenue (US$ Mn) Comparison, By Test Type. 86 8.6.2. Revenue (US$ Mn) Comparison, By End User. 87 Chapter 9. Japan Prostate Cancer Diagnostics Market Analysis and Forecast, By Country, 2016-2031. 88 9.1. Japan Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 88 9.1.1. Revenue (US$ Mn) Comparison, By Test Type. 88 9.1.2. Revenue (US$ Mn) Comparison, By End User. 89 Chapter 10. APEJ Prostate Cancer Diagnostics Market Analysis and Forecast, By Country, 2016-2031. 90 10.1. China Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 90 10.1.1. Revenue (US$ Mn) Comparison, By Test Type. 90 10.1.2. Revenue (US$ Mn) Comparison, By End User. 91 10.2. India Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 92 10.2.1. Revenue (US$ Mn) Comparison, By Test Type. 92 10.2.2. Revenue (US$ Mn) Comparison, By End User. 93 10.3. Malaysia Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 94 10.3.1. Revenue (US$ Mn) Comparison, By Test Type. 94 10.3.2. Revenue (US$ Mn) Comparison, By End User. 95 10.4. Thailand Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 96 10.4.1. Revenue (US$ Mn) Comparison, By Test Type. 96 10.4.2. Revenue (US$ Mn) Comparison, By End User. 97 10.5. Singapore Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 98 10.5.1. Revenue (US$ Mn) Comparison, By Test Type. 98 10.5.2. Revenue (US$ Mn) Comparison, By End User. 99 10.6. Australia Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 100 10.6.1. Revenue (US$ Mn) Comparison, By Test Type. 100 10.6.2. Revenue (US$ Mn) Comparison, By End User. 101 Chapter 11. MEA Prostate Cancer Diagnostics Market Analysis and Forecast, By Country, 2016-2031. 102 11.1. GCC Countries Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 102 11.1.1. Revenue (US$ Mn) Comparison, By Test Type. 102 11.1.2. Revenue (US$ Mn) Comparison, By End User. 103 11.2. South Africa Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 104 11.2.1. Revenue (US$ Mn) Comparison, By Test Type. 104 11.2.2. Revenue (US$ Mn) Comparison, By End User. 105 11.3. Nigeria Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 106 11.3.1. Revenue (US$ Mn) Comparison, By Test Type. 106 11.3.2. Revenue (US$ Mn) Comparison, By End User. 107 11.4. Israel Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 108 11.4.1. Revenue (US$ Mn) Comparison, By Test Type. 108 11.4.2. Revenue (US$ Mn) Comparison, By End User. 109 Chapter 12. Global Prostate Cancer Diagnostics Market Company/Manufactures/Distributors/Suppliers Profile and Revenue Projections. 110 12.1. Abbott Laboratories. 110 12.1.1. Company Overview. 110 12.1.2. Product Overview. 110 12.1.3. Key Financials. 110 12.1.4. Key Developments. 111 12.1.5. SWOT Analysis. 111 12.2. AstraZeneca plc.. 112 12.2.1. Company Overview. 112 12.2.2. Product Overview. 112 12.2.3. Key Financials. 112 12.2.4. Key Developments. 112 12.2.5. SWOT Analysis. 113 12.3. Bayer Aktiengesellschaft. 116 12.3.1. Company Overview. 116 12.3.2. Product Overview. 116 12.3.3. Key Financials. 116 12.3.4. Key Developments. 117 12.3.5. SWOT Analysis. 117 12.4. Danaher Corporation. 120 12.4.1. Company Overview. 120 12.4.2. Product Overview. 120 12.4.3. Key Financials. 121 12.4.4. Key Developments. 121 12.4.5. SWOT Analysis. 121 12.5. Becton, Dickinson and Company. 124 12.5.1. Company Overview. 124 12.5.2. Product Overview. 124 12.5.3. Key Financials. 125 12.5.4. Key Developments. 125 12.5.5. SWOT Analysis. 125 12.6. Foundation Medicine, Inc.. 128 12.6.1. Company Overview. 128 12.6.2. Product Overview. 128 12.6.3. Key Financials. 128 12.7. Cancer Genetics, Inc.. 129 12.7.1. Company Overview. 129 12.7.2. Product Overview. 129 12.7.3. Key Financials. 129 12.7.4. Key Developments. 130 12.8. Myriad Genetics Inc.. 131 12.8.1. Company Overview. 131 12.8.2. Product Overview. 131 12.8.3. Key Financials. 132 12.8.4. Key Developments. 132 12.8.5. SWOT Analysis. 132 12.9. Agilent Technologies. 135 12.9.1. Company Overview. 135 12.9.2. Product Overview. 135 12.9.3. Key Financials. 136 12.9.4. Key Developments. 136 12.9.5. SWOT Analysis. 136 12.10. Biocept, Inc.. 137 12.10.1. Company Overview. 137 12.10.2. Product Overview. 137 12.10.3. Key Financials. 137 12.10.4. Key Developments. 138 Chapter 13. Disclaimer and Contact information. 139
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
TABLE 1 Global Prostate Cancer Diagnostics Market Value (US$ Mn), 2016-2020 22
TABLE 2 Global Prostate Cancer Diagnostics Market Value (US$ Mn), 2021-2031 23
TABLE 3 Global Prostate Cancer Diagnostics Market Value (US$ Mn) and Y-o-Y, 2018-2031 25
TABLE 4 Global PSA Tests Segment Value (US$ Mn), By Region 2016-2020 27
TABLE 5 Global PSA Tests Segment Value (US$ Mn), By Region 2021-2031 28
TABLE 6 Global PSA Tests Segment Market Share, By Region 2016-2020 29
TABLE 7 Global PSA Tests Segment Market Share, By Region 2021-2031 29
TABLE 8 Global PSA Tests Segment Y-o-Y, By Region 2018-2031 29
TABLE 9 Global CTC Tests Segment Value (US$ Mn), By Region 2016-2020 30
TABLE 10 Global CTC Tests Segment Value (US$ Mn), By Region 2021-2031 31
TABLE 11 Global CTC Tests Segment Market Share, By Region 2016-2020 32
TABLE 12 Global CTC Tests Segment Market Share, By Region 2021-2031 32
TABLE 13 Global CTC Tests Segment Y-o-Y, By Region 2018-2031 32
TABLE 14 Global Immunohistochemistry Segment Value (US$ Mn), By Region 2016-2020 33
TABLE 15 Global Immunohistochemistry Segment Value (US$ Mn), By Region 2021-2031 34
TABLE 16 Global Immunohistochemistry Segment Market Share, By Region 2016-2020 35
TABLE 17 Global Immunohistochemistry Segment Market Share, By Region 2021-2031 35
TABLE 18 Global Immunohistochemistry Segment Y-o-Y, By Region 2018-2031 35
TABLE 19 Global PCA3 test Segment Value (US$ Mn), By Region 2016-2020 36
TABLE 20 Global PCA3 test Segment Value (US$ Mn), By Region 2021-2031 37
TABLE 21 Global PCA3 test Segment Market Share, By Region 2016-2020 38
TABLE 22 Global PCA3 test Segment Market Share, By Region 2021-2031 38
TABLE 23 Global PCA3 test Segment Y-o-Y, By Region 2018-2031 38
TABLE 24 Global Others Segment Value (US$ Mn), By Region 2016-2020 39
TABLE 25 Global Others Segment Value (US$ Mn), By Region 2021-2031 40
TABLE 26 Global Others Segment Market Share, By Region 2016-2020 41
TABLE 27 Global Others Segment Market Share, By Region 2021-2031 41
TABLE 28 Global Others Segment Y-o-Y, By Region 2018-2031 41
TABLE 29 Global Hospital Associated Labs Segment Value (US$ Mn), By Region 2016-2020 43
TABLE 30 Global Hospital Associated Labs Segment Value (US$ Mn), By Region 2021-2031 44
TABLE 31 Global Hospital Associated Labs Segment Market Share, By Region 2016-2020 45
TABLE 32 Global Hospital Associated Labs Segment Market Share, By Region 2021-2031 45
TABLE 33 Global Hospital Associated Labs Segment Y-o-Y, By Region 2018-2031 45
TABLE 34 Global Independent Diagnostic Laboratories Segment Value (US$ Mn), By Region 2016-2020 46
TABLE 35 Global Independent Diagnostic Laboratories Segment Value (US$ Mn), By Region 2021-2031 47
TABLE 36 Global Independent Diagnostic Laboratories Segment Market Share, By Region 2016-2020 48
TABLE 37 Global Independent Diagnostic Laboratories Segment Market Share, By Region 2021-2031 48
TABLE 38 Global Independent Diagnostic Laboratories Segment Y-o-Y, By Region 2018-2031 48
TABLE 39 Global Cancer Research Institutes Segment Value (US$ Mn), By Region 2016-2020 49
TABLE 40 Global Cancer Research Institutes Segment Value (US$ Mn), By Region 2021-2031 50
TABLE 41 Global Cancer Research Institutes Segment Market Share, By Region 2016-2020 51
TABLE 42 Global Cancer Research Institutes Segment Market Share, By Region 2021-2031 51
TABLE 43 Global Cancer Research Institutes Segment Y-o-Y, By Region 2018-2031 51
TABLE 44 Global Others Segment Value (US$ Mn), By Region 2016-2020 52
TABLE 45 Global Others Segment Value (US$ Mn), By Region 2021-2031 53
TABLE 46 Global Others Segment Market Share, By Region 2016-2020 54
TABLE 47 Global Others Segment Market Share, By Region 2021-2031 54
TABLE 48 Global Others Segment Y-o-Y, By Region 2018-2031 54
TABLE 49 North America Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 56
TABLE 50 North America Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 56
TABLE 51 North America Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 57
TABLE 52 North America Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 58
TABLE 53 Latin America Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 59
TABLE 54 Latin America Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 60
TABLE 55 Latin America Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 61
TABLE 56 Latin America Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 61
TABLE 57 Europe Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 63
TABLE 58 Europe Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 63
TABLE 59 Europe Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 64
TABLE 60 Europe Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 65
TABLE 61 Japan Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 66
TABLE 62 Japan Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 67
TABLE 63 Japan Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 68
TABLE 64 Japan Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 68
TABLE 65 APEJ Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 69
TABLE 66 APEJ Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 70
TABLE 67 APEJ Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 71
TABLE 68 APEJ Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 72
TABLE 69 MEA Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 73
TABLE 70 MEA Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 73
TABLE 71 MEA Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 74
TABLE 72 MEA Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 75
TABLE 73 US Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 77
TABLE 74 US Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 77
TABLE 75 US Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 78
TABLE 76 US Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 78
TABLE 77 Canada Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 79
TABLE 78 Canada Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 79
TABLE 79 Canada Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 80
TABLE 80 Canada Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 80
TABLE 81 Brazil Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 81
TABLE 82 Brazil Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 81
TABLE 83 Brazil Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 82
TABLE 84 Brazil Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 82
TABLE 85 Mexico Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 83
TABLE 86 Mexico Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 83
TABLE 87 Mexico Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 84
TABLE 88 Mexico Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 84
TABLE 89 Argentina Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 85
TABLE 90 Argentina Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 85
TABLE 91 Argentina Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 86
TABLE 92 Argentina Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 86
TABLE 93 Germany Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 87
TABLE 94 Germany Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 87
TABLE 95 Germany Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 88
TABLE 96 Germany Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 88
TABLE 97 UK Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 89
TABLE 98 UK Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 89
TABLE 99 UK Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 90
TABLE 100 UK Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 90
TABLE 101 France Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 91
TABLE 102 France Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 91
TABLE 103 France Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 92
TABLE 104 France Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 92
TABLE 105 Spain Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 93
TABLE 106 Spain Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 93
TABLE 107 Spain Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 94
TABLE 108 Spain Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 94
TABLE 109 Italy Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 95
TABLE 110 Italy Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 95
TABLE 111 Italy Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 96
TABLE 112 Italy Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 96
TABLE 113 Nordic Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 97
TABLE 114 Nordic Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 97
TABLE 115 Nordic Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 98
TABLE 116 Nordic Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 98
TABLE 117 Japan Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 99
TABLE 118 Japan Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 99
TABLE 119 Japan Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 100
TABLE 120 Japan Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 100
TABLE 121 China Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 101
TABLE 122 China Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 101
TABLE 123 China Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 102
TABLE 124 China Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 102
TABLE 125 India Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 103
TABLE 126 India Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 103
TABLE 127 India Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 104
TABLE 128 India Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 104
TABLE 129 Malaysia Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 105
TABLE 130 Malaysia Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 105
TABLE 131 Malaysia Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 106
TABLE 132 Malaysia Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 106
TABLE 133 Thailand Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 107
TABLE 134 Thailand Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 107
TABLE 135 Thailand Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 108
TABLE 136 Thailand Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 108
TABLE 137 Singapore Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 109
TABLE 138 Singapore Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 109
TABLE 139 Singapore Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 110
TABLE 140 Singapore Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 110
TABLE 141 Australia Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 111
TABLE 142 Australia Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 111
TABLE 143 Australia Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 112
TABLE 144 Australia Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 112
TABLE 145 GCC Countries Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 113
TABLE 146 GCC Countries Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 113
TABLE 147 GCC Countries Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 114
TABLE 148 GCC Countries Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 114
TABLE 149 South Africa Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 115
TABLE 150 South Africa Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 115
TABLE 151 South Africa Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 116
TABLE 152 South Africa Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 116
TABLE 153 Nigeria Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 117
TABLE 154 Nigeria Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 117
TABLE 155 Nigeria Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 118
TABLE 156 Nigeria Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 118
TABLE 157 Israel Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 119
TABLE 158 Israel Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 119
TABLE 159 Israel Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 120
TABLE 160 Israel Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 120
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
FIG. 1 Global Prostate Cancer Diagnostics Market Value (US$ Mn), 2016-2020 15
FIG. 2 Global Prostate Cancer Diagnostics Market Value (US$ Mn) Forecast, 2021-2031 15
FIG. 3 Global Prostate Cancer Diagnostics Market Value (US$ Mn) and Y-o-Y, 2018-2031 17
FIG. 4 Global PSA Tests Segment Market Value (US$ Mn) By Region, 2016-2020 19
FIG. 5 Global PSA Tests Segment Market Value (US$ Mn) By Region, 2021-2031 20
FIG. 6 Global PSA Tests Segment Y-o-Y Growth Rate, By Region, 2018-2031 22
FIG. 7 Global CTC Tests Segment Market Value (US$ Mn) By Region, 2016-2020 22
FIG. 8 Global CTC Tests Segment Market Value (US$ Mn) By Region, 2021-2031 23
FIG. 9 Global CTC Tests Segment Y-o-Y Growth Rate, By Region, 2018-2031 25
FIG. 10 Global Immunohistochemistry Segment Market Value (US$ Mn) By Region, 2016-2020 25
FIG. 11 Global Immunohistochemistry Segment Market Value (US$ Mn) By Region, 2021-2031 26
FIG. 12 Global Immunohistochemistry Segment Y-o-Y Growth Rate, By Region, 2018-2031 28
FIG. 13 Global PCA3 test Segment Market Value (US$ Mn) By Region, 2016-2020 28
FIG. 14 Global PCA3 test Segment Market Value (US$ Mn) By Region, 2021-2031 29
FIG. 15 Global PCA3 test Segment Y-o-Y Growth Rate, By Region, 2018-2031 31
FIG. 16 Global Others Segment Market Value (US$ Mn) By Region, 2016-2020 31
FIG. 17 Global Others Segment Market Value (US$ Mn) By Region, 2021-2031 32
FIG. 18 Global Others Segment Y-o-Y Growth Rate, By Region, 2018-2031 34
FIG. 19 Global Hospital Associated Labs Segment Market Value (US$ Mn) By Region, 2016-2020 35
FIG. 20 Global Hospital Associated Labs Segment Market Value (US$ Mn) By Region, 2021-2031 36
FIG. 21 Global Hospital Associated Labs Segment Y-o-Y Growth Rate, By Region, 2018-2031 38
FIG. 22 Global Independent Diagnostic Laboratories Segment Market Value (US$ Mn) By Region, 2016-2020 38
FIG. 23 Global Independent Diagnostic Laboratories Segment Market Value (US$ Mn) By Region, 2021-2031 39
FIG. 24 Global Independent Diagnostic Laboratories Segment Y-o-Y Growth Rate, By Region, 2018-2031 41
FIG. 25 Global Cancer Research Institutes Segment Market Value (US$ Mn) By Region, 2016-2020 41
FIG. 26 Global Cancer Research Institutes Segment Market Value (US$ Mn) By Region, 2021-2031 42
FIG. 27 Global Cancer Research Institutes Segment Y-o-Y Growth Rate, By Region, 2018-2031 44
FIG. 28 Global Others Segment Market Value (US$ Mn) By Region, 2016-2020 44
FIG. 29 Global Others Segment Market Value (US$ Mn) By Region, 2021-2031 45
FIG. 30 Global Others Segment Y-o-Y Growth Rate, By Region, 2018-2031 47
FIG. 31 North America Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 48
FIG. 32 North America Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 49
FIG. 33 North America Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 50
FIG. 34 North America Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 50
FIG. 35 Latin America Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 51
FIG. 36 Latin America Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 52
FIG. 37 Latin America Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 53
FIG. 38 Latin America Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 54
FIG. 39 Europe Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 55
FIG. 40 Europe Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 56
FIG. 41 Europe Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 57
FIG. 42 Europe Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 57
FIG. 43 Japan Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 58
FIG. 44 Japan Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 59
FIG. 45 Japan Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 60
FIG. 46 Japan Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 61
FIG. 47 APEJ Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 62
FIG. 48 APEJ Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 62
FIG. 49 APEJ Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 63
FIG. 50 APEJ Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 64
FIG. 51 MEA Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 65
FIG. 52 MEA Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 66
FIG. 53 MEA Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 67
FIG. 54 MEA Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 67
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request